Vycor Medical, Inc. (VYCO)
OTCMKTS
· Delayed Price · Currency is USD
0.1150
+0.0150 (15.00%)
Jun 13, 2025, 1:52 PM EDT
Vycor Medical Revenue
Vycor Medical had revenue of $436.38K in the quarter ending March 31, 2025, with 29.50% growth. This brings the company's revenue in the last twelve months to $1.69M, up 17.55% year-over-year. In the year 2024, Vycor Medical had annual revenue of $1.59M with 8.81% growth.
Revenue (ttm)
1.69M
Revenue Growth
+17.55%
P/S Ratio
2.27
Revenue / Employee
241.25K
Employees
7
Market Cap
3.84M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.59M | 128.72K | 8.81% |
Dec 31, 2023 | 1.46M | 237.62K | 19.43% |
Dec 31, 2022 | 1.22M | -170.00K | -12.20% |
Dec 31, 2021 | 1.39M | 250.94K | 21.97% |
Dec 31, 2020 | 1.14M | -250.86K | -18.01% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Northwest Biotherapeutics | 1.47M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |